Merck to Hold Investor Event to Highlight Growing Cardiovascular Portfolio and Pipeline Life Science Investing
U.S. Food and Drug Administration Approves Opdivo® with Chemotherapy as Neoadjuvant Treatment for Certain Adult Patients with Resectable Non-Small Cell Lung Cancer Pharmaceutical Investing
Love Pharma Updates Microdoz Proposed Acquisition with Global Leader in Psychedelic Research Pharmaceutical Investing
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurinia Pharmaceuticals Inc. - AUPH Pharmaceutical Investing
Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers Pharmaceutical Investing
Ortho Dermatologics Now Accepting Applications for 2022 Aspire Higher Scholarship Program Pharmaceutical Investing
Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV in Infants from Birth up to Six Months of Age by Active Immunization of Pregnant Women Life Science Investing
Bristol Myers Squibb Announces Early Participation Results, Upsizing and Early Settlement of Tender Offers Pharmaceutical Investing
Dragonfly Therapeutics Announces Achievement of Phase 1 Clinical Development Milestone for IL-12 Investigational Immunotherapy Program with Bristol Myers Squibb Pharmaceutical Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
